
Sign up to save your podcasts
Or


A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
By RBC Capital Markets5
1212 ratings
A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

3,227 Listeners

1,731 Listeners

977 Listeners

1,989 Listeners

1,654 Listeners

1,096 Listeners

126 Listeners

337 Listeners

1,043 Listeners

1,316 Listeners

6,131 Listeners

34 Listeners

40 Listeners

21 Listeners

10 Listeners

0 Listeners

86 Listeners

18 Listeners

15 Listeners

3 Listeners